Collplant biotechnologies announces date for first quarter financial results

Rehovot, israel , may 14, 2025 /prnewswire/ -- collplant biotechnologies (nasdaq: clgn), a regenerative and aesthetics medicine company developing innovative technologies and products based on its non-animal-derived, rhcollagen for tissue regeneration and medical aesthetics, today announced that it will report financial results for the first quarter on wednesday, may 28, 2025, before the opening of the u.s. financial markets. about collplant collplant is a regenerative and aesthetic medicine company ushering in a new era of medical solutions with a focus on 3d bioprinting of tissues and organs, tissue repair and medical aesthetics.
CLGN Ratings Summary
CLGN Quant Ranking